Mexico - Delayed Quote MXN
Eli Lilly and Company (LLY.MX)
16,785.00
+685.00
+(4.25%)
At close: April 24 at 1:36:36 PM CST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALVAREZ RALPH Director | Stock Award(Grant) | Apr 21, 2025 | 54,847 |
| DOZIER ERIC Officer | Conversion of Exercise of derivative security | Feb 28, 2025 | 10,173 |
| FYRWALD J. ERIK Director | Stock Award(Grant) | Apr 21, 2025 | 72,839 |
| HEDLEY MARY LYNNE Director | Stock Award(Grant) | Apr 21, 2025 | 2,029 |
| HERNANDEZ EDGARDO President | Conversion of Exercise of derivative security | Feb 28, 2025 | 40,616 |
| LILLY ENDOWMENT, INC. Beneficial Owner of more than 10% of a Class of Security | Sale | Mar 3, 2025 | 96,017,000 |
| LUCIANO JUAN R Director | Stock Award(Grant) | Apr 21, 2025 | 16,294 |
| RICKS DAVID A Chief Executive Officer | Stock Award(Grant) | Feb 10, 2025 | 675,291 |
| SULZBERGER GABRIELLE Director | Stock Award(Grant) | Apr 21, 2025 | 2,562 |
| ZAKROWSKI DONALD A Officer | Sale | Mar 13, 2025 | 7,559 |
Related Tickers
JNJ.VI Johnson & Johnson
135.98
-0.41%
JNJ.MX Johnson & Johnson
3,037.00
-1.65%
PFE.MX Pfizer Inc.
446.20
+1.42%
SNW.HM Sanofi SA
93.40
+0.33%
JNJ.BA Johnson & Johnson
12,400.00
+1.22%
NNO2.VI Novo Nordisk A/S
54.95
+0.53%
GRF.MC Grifols, S.A.
8.45
+0.64%
NOV.DE Novo Nordisk A/S
54.96
+1.33%
GSK GSK plc
37.50
+1.27%
NVO Novo Nordisk A/S
62.63
+2.17%